Natural Capsules Ltd.

View in App
345.45 -1.20 ▼-0.4%

09 June 2023, 04:01:00 PM
Volume: 29,912

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.naturalcapsules.com
Market Cap 322.96 Cr.
Enterprise Value(EV) 412.57 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 19.72 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 17.51 Trailing Twelve Months Ending 2023-03
Industry PE 33.57 Trailing Twelve Months Ending 2023-03
Book Value / Share 131.89 Trailing Twelve Months Ending 2023-03
Price to Book Value 2.62 Calculated using Price: 345.45
Dividend Yield 0.29 Period Ending 2022-03
No. of Shares Subscribed 0.93 Cr. 9,349,050 Shares
FaceValue 10
About Natural Capsules Ltd.
Natural Capsules is a public limited company established in the year 1993.The company is a well-equipped modern manufacturing plant to manufacture hard gelatin capsule shells, Hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.

Natural Capsules Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Natural Capsules Ltd. Performance

View details >>
1 Day
-0.35%
1 Week
-1.37%
1 Month
-24.28%
3 Month
-19.45%
6 Month
-33.97%
1 Year
-20.98%
2 Year
+171.00%
5 Year
+322.57%
10 Year
+1157.55%

Natural Capsules Ltd. Fundamental Ratios

View details >>
5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.05 3.50 1.54 11.74 19.18
Return on Capital Employed (%) 3.71 4.51 3.71 14.52 20.92
Return on Assets (%) 1.56 2.66 1.16 8.05 10.65

Natural Capsules Ltd. Balance Sheet

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 54 55 56 62 83 123
Non Curr. Liab. 2 1 1 2 35 74
Curr. Liab. 15 16 18 33 46 67
Minority Int.
Equity & Liab. 71 73 75 97 164 289
Non Curr. Assets 29 35 37 47 89 187
Curr. Assets 42 38 38 50 76 101
Misc. Exp. not W/O
Total Assets 71 73 75 97 164 289

Natural Capsules Ltd. Profit and Loss

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 55 60 62 80 135 172
Other Income 1 1 1 1 2 1
Total Income 56 61 63 80 137 173
Total Expenditure -49 -55 -56 -68 -111 -137
PBIDT 6 6 6 12 27 36
Interest 0 -1 -1 -1 -2 -3
Depreciation -4 -3 -4 -4 -5 -7
Taxation -1 0 -1 -2 -5 -7
Exceptional Items 0 2
PAT 1 2 1 7 14 18
Minority Interest
Share Associate
Other Related Items 0 0
Consolidated Net Profit 1 2 1 7 14 18
Adjusted EPS 1 3 1 9 20 23

Natural Capsules Ltd. Cash Flow

View details >>
Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 5 2 7 6 1
Cash Fr. Inv. -1 -7 -6 -9 -46
Cash Fr. Finan. -4 4 -1 3 46
Net Change 0 -1 0 0 1
Cash & Cash Eqvt 1 0 0 0 1

Natural Capsules Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 54.37 54.37 54.38 56.58 56.57 56.57 56.56 56.56 56.56
Public 45.63 45.63 45.62 43.42 43.43 43.43 43.44 43.44 43.44
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Natural Capsules Ltd. Announcements

View details >>
Fri, 09 Jun 2023
Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We wish to inform you that M/S SOMERSET INDUS HEALTHCARE FUND II have invested Rs. 31 38 48 225/- (Rupees Thirty One Crore Thirty Eight Lakhs Forty Eight Thousand Two Hundred Twenty Five Only) in Subsidiary Company M/S Natural Biogenex Private Limited at a pre money valuation of Rs. 250 crores. The Board of M/S Natural Biogenex Private Limited (Subsidiary) on their meeting held today i.e. 09.06.2023 have considered and approved Allotment of 27 89 762 Cumulative Compulsorily Convertible Preference Shares (CCPS) of Rs. 70/- each at Rs. 112.50 per shares (including premium of Rs. 42.50/-) to M/S SOMERSET INDUS HEALTHCARE FUND II.
Fri, 09 Jun 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
With reference to the captioned subject We hereby inform that Notice to the shareholders for transfer of shares to Investors Education & Protection Fund (IEPF) has been published in Business Line-An English daily & Sanjevani- a Kannada daily.We enclose herewith the copies of Newspaper for your reference and records.
Thu, 08 Jun 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing obligations & Disclosure Requirements) Regulations 2015 we wish to bring to inform that 2 shareholders have reported to company about loss of their share certificates and requested the Company to issue a duplicate share certificate. The particulars relating to loss of share certificate are attached herewith.

Natural Capsules Ltd. Technical Scans

View details >>
Fri, 09 Jun 2023
High Delivery Percentage High Delivery Percentage
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 6 Months High Decrease in 6 Months

Natural Capsules Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,890.62 983.15 -0.4%
Divi's Laboratories Ltd. 90,973.43 3,426.90 -2.1%
Cipla Ltd. 78,191.79 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. 77,768.81 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. 70,817.54 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. 61,150.32 1,810.90 +0.8%
Mankind Pharma Ltd. 59,389.24 1,482.30 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.84 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 49.89 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 27.91 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.25 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.63 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 49.23 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 46.32 1,482.30 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.13 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 3.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.34 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.46 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.89 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 5.05 1,482.30 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 0.04 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,482.30 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,482.30 +1.8%

Natural Capsules Ltd. FAQ's

What is Natural Capsules share price?
Can I buy Natural Capsules shares now?
What is the Dividend Yield of Natural Capsules?
What is the Market Cap of Natural Capsules?
What are the key metrics to analyse Natural Capsules?
What is the 52 Week High and Low of Natural Capsules?
What is the trend of Natural Capsules share price?